Show simple item record

dc.creatorLasso B,Martín
dc.creatorPérez G,Jorge
dc.creatorNoriega R,L. Miguel
dc.creatorNorthland A,Rebeca
dc.date2000-10-01
dc.date.accessioned2020-02-17T15:25:53Z
dc.date.available2020-02-17T15:25:53Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001000010
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/126396
dc.descriptionType B lactic acidosis occurs without any evidence of cellular hypoxia and is associated with the use of drugs or toxins. We report a 36 years old woman with acquired immunodeficiency syndrome that was admitted to the hospital with a severe lactic acidosis. She had been treated with didanosine, stavudine and efavirenz for four months prior to admission. Despite the use of high bicarbonate doses and vasoactive drugs, the patient had a catastrophic evolution and died in shock and multiple organ failure, 68 hours after admission. (Rev Méd Chile 2000; 128: 1139-43).
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872000001000010
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.128 n.10 2000
dc.subjectAcquired immunodeficiency syndrome
dc.subjectAntiviral agents
dc.subjectDidanosine
dc.subjectEfavirenz
dc.subjectStavudine
dc.titleAcidosis láctica fatal en paciente con síndrome de inmunodeficiencia adquirido y tratamiento antiretroviral de alto grado de actividad: comunicación de un caso


This item appears in the following Collection(s)

Show simple item record